Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$19.26 - $30.08 $98,360 - $153,618
-5,107 Closed
0 $0
Q3 2021

Nov 10, 2021

SELL
$24.86 - $35.02 $150,104 - $211,450
-6,038 Reduced 54.18%
5,107 $131,000
Q2 2021

Aug 09, 2021

SELL
$22.3 - $36.02 $155,297 - $250,843
-6,964 Reduced 38.46%
11,145 $390,000
Q1 2021

May 14, 2021

SELL
$26.38 - $51.15 $648,156 - $1.26 Million
-24,570 Reduced 57.57%
18,109 $603,000
Q4 2020

Feb 11, 2021

BUY
$10.5 - $28.5 $148,648 - $403,474
14,157 Added 49.64%
42,679 $1.11 Million
Q3 2020

Nov 12, 2020

BUY
$3.61 - $9.87 $102,964 - $281,512
28,522 New
28,522 $282,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track O'Shaughnessy Asset Management, LLC Portfolio

Follow O'Shaughnessy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.